Rousselot launches Nextida, a collagen peptide platform for targeted health benefits
Rousselot, a Darling Ingredients brand, has announced the launch of Nextida, a platform of specific collagen peptide compositions for targeted health benefits.
Image courtesy of Rousselot
Rousselot, a Darling Ingredients (Irvine, TX) brand, has announced the launch of Nextida, a platform of specific collagen peptide compositions for targeted health benefits. The company states that it will be doing comprehensive testing and validation as well as conducting clinical studies to evaluate the efficacy of these compositions. The first of the Nextida compositions Rousselot is commercializing is Nextida.GC, which is designed to reduce post meal sugar spikes. Results of scientific research demonstrating the glucose metabolism benefits of the composition will be unveiled at the upcoming SupplySide West in Las Vegas, NV, taking place October 28-31, 2024.
“After years of cutting-edge research into the collagen molecule, Rousselot is proud to launch Nextida, offering new health benefits beyond those traditionally attributed to collagen peptides. Nextida’s strength and innovation is to act where it matters,” said Jeroen Colpaert, executive vice president of Rousselot, in a press release.
"This new product marks the beginning of a long series of innovations, building on Rousselot's unique scientific and production excellence,” Colpaert added. "We are incredibly excited to open new market opportunities with Nextida and to further empower customers who are looking for natural health and wellness products."
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
